The 12% return this week takes Remedy Entertainment Oyj’s (HEL:REMEDY) shareholders five-year gains to 138%

While Remedy Entertainment Oyj (HEL:REMEDY) shareholders are probably generally happy, the stock hasn’t had particularly good run recently, with the share price falling 24% in the last quarter. But that scarcely detracts from the really solid long term returns generated by the company over five years. We think most investors would be happy with the 133% return, over that period. Generally speaking the long term returns will give you a better idea of business quality than short periods can. Of course, that doesn’t necessarily mean it’s cheap now. While the returns over the last 5 years have been good, we do feel sorry for those shareholders who haven’t held shares that long, because the share price is down 59% in the last three years.

After a strong gain in the past week, it’s worth seeing if longer term returns have been driven by improving fundamentals.

Check out our latest analysis for Remedy Entertainment Oyj

Remedy Entertainment Oyj isn’t currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. When a company doesn’t make profits, we’d generally hope to see good revenue growth. That’s because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

For the last half decade, Remedy Entertainment Oyj can boast revenue growth at a rate of 8.2% per year. That’s a pretty good long term growth rate. Broadly speaking, this solid progress may well be reflected by the healthy share price gain of 18% per year over five years. It’s well worth monitoring the growth trend in revenue, because if growth accelerates, that might signal an opportunity. Accelerating growth can be a sign of an inflection point – and could indicate profits lie ahead. Worth watching 100%

The company’s revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

What About The Total Shareholder Return (TSR)?

Investors should note that there’s a difference between Remedy Entertainment Oyj’s total shareholder return (TSR) and its share price change, which we’ve covered above. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Its history of dividend payouts mean that Remedy Entertainment Oyj’s TSR of 138% over the last 5 years is better than the share price return.

A Different Perspective

We regret to report that Remedy Entertainment Oyj shareholders are down 23% for the year. Unfortunately, that’s worse than the broader market decline of 6.9%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there’s a good opportunity. Longer term investors wouldn’t be so upset, since they would have made 19%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. It’s always interesting to track share price performance over the longer term. But to understand Remedy Entertainment Oyj better, we need to consider many other factors. Take risks, for example – Remedy Entertainment Oyj has 1 warning sign we think you should be aware of.

But note: Remedy Entertainment Oyj may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Finnish exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.